Reagents and instruments for immunology, cell biology and molecular biology.
 
> CD3 Monoclonal Antibody (Muromonab Biosimilar) in vivo

CD3 Monoclonal Antibody (Muromonab Biosimilar) in vivo

Print Print
Please log in

Cat# TA410386

Size : 1mg

Contact local distributor :


Phone :

CD3 Monoclonal Antibody (Muromonab Biosimilar) in vivo

Be the first to review this product
SKU
TA410386
anti-Human CD3 Recombinant Monoclonal Antibody (Muromonab Biosimilar) in vivo Grade
Size:
1 mg
Conjugation:
Unconjugated
 

View other "CD3E" antibodies

  • cDNA Clones
  • Lentiviral
  • AAV
  • CRISPR
  • RNAi
  • Proteins
  • Antibodies
Specifications
Product Data
Clone Name Muromonab
Application Animal Model, ELISA, FC
Recommended Dilution Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Reactivity Human
Antibody Host Mammalian Cells
Isotype IgG2a, kappa
Clonality Monoclonal
Immunogen Human CD3
Buffer 0.2 μm sterile-filtered, 1 x PBS, pH 7.4
Concentration Lot-dependent
Purity >95% by reducing SDS-PAGE
Exotoxin < 1 EU per 1 mg of the protein by the LAL method (In vivo grade)
Purification Protein A or G purification
Conjugation Unconjugated
Stability 12 months from date of receipt when stored at -20 to -70°C or 1 month from date of receipt when stored at 2 to 8°C
Shipping Blue Ice
Predicted Protein Size ~150 kDa
Gene Name CD3e molecule
Database Link
Background Muromonab Biosimilar uses the same protein sequences as the therapeutic antibody muromonab (OKT3). Muromonab (OKT-3) is a monoclonal anti-CD3 antibody used as immunosuppressive therapy in kidney, heart, and liver transplant patients.
Synonyms CD3-epsilon; FLJ18683; T3E; TCRE
Reference Data
Product Manuals
FAQs
  • Antibody and Western Standard
SDS
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products